The invention provides compounds of formula I
and pharmaceutically acceptable salts thereof.
The formula I compounds inhibit protein kinase activity thereby making them useful as anticancer agents.
US8212031B2
申请人:——
公开号:US8212031B2
公开(公告)日:2012-07-03
[EN] PYRROLOTRIAZINE KINASE INHIBITORS<br/>[FR] INHIBITEURS DE LA PYRROLOTRIAZINE KINASE
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2009111531A1
公开(公告)日:2009-09-11
The invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof. The formula I compounds inhibit protein kinase activity thereby making them useful as anticancer agents.